Skip to main content
The Maple Markets

Toronto Stock Exchange (TSX) · NOVO.TO · ISIN CA67010P1018

Novo Nordisk A/S

18.49 CAD

+0.11(+0.60%)up

Previous close · Sep 18, 15:48 ET

Data last updated: (20 h ago)· Delayed exchange data

Sign in to add to portfolio

Novo Nordisk A/S (NOVO.TO) trades on the Toronto Stock Exchange and operates in the Drug Manufacturers - General industry. Its market capitalisation is approximately 60.93B CAD. The company reports around 68,794 employees. Its ISIN is CA67010P1018. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Toronto Stock Exchange (TSX)

ISIN

CA67010P1018

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

DK

Market cap

61.87B CAD

Employees

68.79K

Previous close

18.38 CAD

Day range

18.32 – 18.52

52-week range

14.88 – 27.58

Volume

745

50-day average

19.89 CAD

200-day average

19.43 CAD

Asset type

Equity

About Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Company website

Frequently asked

+
What is the NOVO.TO share price today?
This page shows the latest available Novo Nordisk A/S (NOVO.TO) price with its change against the prior close. Values are delayed or previous-close, not real-time.
+
Where is Novo Nordisk A/S listed?
Novo Nordisk A/S trades on the Toronto Stock Exchange under the symbol NOVO.TO, ISIN CA67010P1018.
+
How large is Novo Nordisk A/S?
Its market capitalisation is approximately 60.93B CAD, based on the latest available price and share count from our data provider.

All Novo Nordisk A/S data comes from exchange and provider feeds for the Toronto Stock Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.

We use necessary cookies to run the site and, only with your permission, analytics cookies to understand what readers use. Cookie policy